Phentolamine Reverses Epinephrine-Enhanced Skin Antinociception of Dibucaine in Rats

An Kuo Chou, Chong Chi Chiu, Yu Wen Chen, Jhi Joung Wang, Ching Hsia Hung

研究成果: Article

1 引文 (Scopus)

摘要

BACKGROUND: The objective of the experiment was to assess the antinociceptive effect of dibucaine, bupivacaine, and epinephrine. To assess the mechanism of action of the interaction between dibucaine and epinephrine, phentolamine, a nonselective α-adrenergic antagonist, was added to the mixture. METHODS: We assessed sensory blockade with these drugs by injecting 0.6 mL of drug-in-saline in the dorsal thoracolumbar area of rats; pinprick of the "wheal" formed by the injectate was the area targeted for stimulation to elicit a cutaneous trunci muscle reflex. The sensory block of dibucaine was compared with that of bupivacaine or epinephrine. Drug-drug interactions were analyzed by isobologram. Phentolamine was added to investigate the antinociceptive effect of dibucaine coinjected with epinephrine. RESULTS: We demonstrated that dibucaine, epinephrine, and bupivacaine produced dose-dependent skin antinociception. On the median effective dose (ED50) basis, the potency was higher for epinephrine (mean, 0.011 [95% confidence interval {CI}, 0.007-0.015] μmol) than for dibucaine (mean, 0.493 [95% CI, 0.435-0.560] μmol) (P <.01), while there were no significant differences between dibucaine and bupivacaine (mean, 0.450 [95% CI, 0.400-0.505] μmol). On the equipotent basis (75% effective dose, median effective dose, and 25% effective dose), sensory block duration provoked by epinephrine was greater (P <.01) than that provoked by dibucaine or bupivacaine. Coadministration of dibucaine with epinephrine produced a synergistic nociceptive block, whereas phentolamine blocked that synergistic block. CONCLUSIONS: The preclinical data indicated that there is no statistically significant difference between the potency and duration of dibucaine and bupivacaine in this model. Epinephrine synergistically enhances the effects of dibucaine, while phentolamine partially blocked those effects. α-Adrenergic receptors play an important role in controlling synergistic analgesic effect of dibucaine combined with epinephrine.

原文English
頁(從 - 到)1336-1343
頁數8
期刊Anesthesia and analgesia
128
發行號6
DOIs
出版狀態Published - 2019 六月 1

指紋

Dibucaine
Phentolamine
Epinephrine
Skin
Bupivacaine
Confidence Intervals
Pharmaceutical Preparations
Adrenergic Antagonists
Drug Interactions
Adrenergic Receptors
Reflex
Analgesics

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

引用此文

Chou, An Kuo ; Chiu, Chong Chi ; Chen, Yu Wen ; Wang, Jhi Joung ; Hung, Ching Hsia. / Phentolamine Reverses Epinephrine-Enhanced Skin Antinociception of Dibucaine in Rats. 於: Anesthesia and analgesia. 2019 ; 卷 128, 編號 6. 頁 1336-1343.
@article{535d29926bff4e6ea8c1361daf88cbc2,
title = "Phentolamine Reverses Epinephrine-Enhanced Skin Antinociception of Dibucaine in Rats",
abstract = "BACKGROUND: The objective of the experiment was to assess the antinociceptive effect of dibucaine, bupivacaine, and epinephrine. To assess the mechanism of action of the interaction between dibucaine and epinephrine, phentolamine, a nonselective α-adrenergic antagonist, was added to the mixture. METHODS: We assessed sensory blockade with these drugs by injecting 0.6 mL of drug-in-saline in the dorsal thoracolumbar area of rats; pinprick of the {"}wheal{"} formed by the injectate was the area targeted for stimulation to elicit a cutaneous trunci muscle reflex. The sensory block of dibucaine was compared with that of bupivacaine or epinephrine. Drug-drug interactions were analyzed by isobologram. Phentolamine was added to investigate the antinociceptive effect of dibucaine coinjected with epinephrine. RESULTS: We demonstrated that dibucaine, epinephrine, and bupivacaine produced dose-dependent skin antinociception. On the median effective dose (ED50) basis, the potency was higher for epinephrine (mean, 0.011 [95{\%} confidence interval {CI}, 0.007-0.015] μmol) than for dibucaine (mean, 0.493 [95{\%} CI, 0.435-0.560] μmol) (P <.01), while there were no significant differences between dibucaine and bupivacaine (mean, 0.450 [95{\%} CI, 0.400-0.505] μmol). On the equipotent basis (75{\%} effective dose, median effective dose, and 25{\%} effective dose), sensory block duration provoked by epinephrine was greater (P <.01) than that provoked by dibucaine or bupivacaine. Coadministration of dibucaine with epinephrine produced a synergistic nociceptive block, whereas phentolamine blocked that synergistic block. CONCLUSIONS: The preclinical data indicated that there is no statistically significant difference between the potency and duration of dibucaine and bupivacaine in this model. Epinephrine synergistically enhances the effects of dibucaine, while phentolamine partially blocked those effects. α-Adrenergic receptors play an important role in controlling synergistic analgesic effect of dibucaine combined with epinephrine.",
author = "Chou, {An Kuo} and Chiu, {Chong Chi} and Chen, {Yu Wen} and Wang, {Jhi Joung} and Hung, {Ching Hsia}",
year = "2019",
month = "6",
day = "1",
doi = "10.1213/ANE.0000000000003421",
language = "English",
volume = "128",
pages = "1336--1343",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

Phentolamine Reverses Epinephrine-Enhanced Skin Antinociception of Dibucaine in Rats. / Chou, An Kuo; Chiu, Chong Chi; Chen, Yu Wen; Wang, Jhi Joung; Hung, Ching Hsia.

於: Anesthesia and analgesia, 卷 128, 編號 6, 01.06.2019, p. 1336-1343.

研究成果: Article

TY - JOUR

T1 - Phentolamine Reverses Epinephrine-Enhanced Skin Antinociception of Dibucaine in Rats

AU - Chou, An Kuo

AU - Chiu, Chong Chi

AU - Chen, Yu Wen

AU - Wang, Jhi Joung

AU - Hung, Ching Hsia

PY - 2019/6/1

Y1 - 2019/6/1

N2 - BACKGROUND: The objective of the experiment was to assess the antinociceptive effect of dibucaine, bupivacaine, and epinephrine. To assess the mechanism of action of the interaction between dibucaine and epinephrine, phentolamine, a nonselective α-adrenergic antagonist, was added to the mixture. METHODS: We assessed sensory blockade with these drugs by injecting 0.6 mL of drug-in-saline in the dorsal thoracolumbar area of rats; pinprick of the "wheal" formed by the injectate was the area targeted for stimulation to elicit a cutaneous trunci muscle reflex. The sensory block of dibucaine was compared with that of bupivacaine or epinephrine. Drug-drug interactions were analyzed by isobologram. Phentolamine was added to investigate the antinociceptive effect of dibucaine coinjected with epinephrine. RESULTS: We demonstrated that dibucaine, epinephrine, and bupivacaine produced dose-dependent skin antinociception. On the median effective dose (ED50) basis, the potency was higher for epinephrine (mean, 0.011 [95% confidence interval {CI}, 0.007-0.015] μmol) than for dibucaine (mean, 0.493 [95% CI, 0.435-0.560] μmol) (P <.01), while there were no significant differences between dibucaine and bupivacaine (mean, 0.450 [95% CI, 0.400-0.505] μmol). On the equipotent basis (75% effective dose, median effective dose, and 25% effective dose), sensory block duration provoked by epinephrine was greater (P <.01) than that provoked by dibucaine or bupivacaine. Coadministration of dibucaine with epinephrine produced a synergistic nociceptive block, whereas phentolamine blocked that synergistic block. CONCLUSIONS: The preclinical data indicated that there is no statistically significant difference between the potency and duration of dibucaine and bupivacaine in this model. Epinephrine synergistically enhances the effects of dibucaine, while phentolamine partially blocked those effects. α-Adrenergic receptors play an important role in controlling synergistic analgesic effect of dibucaine combined with epinephrine.

AB - BACKGROUND: The objective of the experiment was to assess the antinociceptive effect of dibucaine, bupivacaine, and epinephrine. To assess the mechanism of action of the interaction between dibucaine and epinephrine, phentolamine, a nonselective α-adrenergic antagonist, was added to the mixture. METHODS: We assessed sensory blockade with these drugs by injecting 0.6 mL of drug-in-saline in the dorsal thoracolumbar area of rats; pinprick of the "wheal" formed by the injectate was the area targeted for stimulation to elicit a cutaneous trunci muscle reflex. The sensory block of dibucaine was compared with that of bupivacaine or epinephrine. Drug-drug interactions were analyzed by isobologram. Phentolamine was added to investigate the antinociceptive effect of dibucaine coinjected with epinephrine. RESULTS: We demonstrated that dibucaine, epinephrine, and bupivacaine produced dose-dependent skin antinociception. On the median effective dose (ED50) basis, the potency was higher for epinephrine (mean, 0.011 [95% confidence interval {CI}, 0.007-0.015] μmol) than for dibucaine (mean, 0.493 [95% CI, 0.435-0.560] μmol) (P <.01), while there were no significant differences between dibucaine and bupivacaine (mean, 0.450 [95% CI, 0.400-0.505] μmol). On the equipotent basis (75% effective dose, median effective dose, and 25% effective dose), sensory block duration provoked by epinephrine was greater (P <.01) than that provoked by dibucaine or bupivacaine. Coadministration of dibucaine with epinephrine produced a synergistic nociceptive block, whereas phentolamine blocked that synergistic block. CONCLUSIONS: The preclinical data indicated that there is no statistically significant difference between the potency and duration of dibucaine and bupivacaine in this model. Epinephrine synergistically enhances the effects of dibucaine, while phentolamine partially blocked those effects. α-Adrenergic receptors play an important role in controlling synergistic analgesic effect of dibucaine combined with epinephrine.

UR - http://www.scopus.com/inward/record.url?scp=85066818375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066818375&partnerID=8YFLogxK

U2 - 10.1213/ANE.0000000000003421

DO - 10.1213/ANE.0000000000003421

M3 - Article

C2 - 31094809

AN - SCOPUS:85066818375

VL - 128

SP - 1336

EP - 1343

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 6

ER -